Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daprodustat in rhEPO-naïve non-dialysis CKD patients with anemia (ASCEND-ND)
NCT03409107Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2018
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 14
01
Overview
Phase 3, randomised, double-blind trial of daprodustat in anemia of chronic kidney disease, sponsored by GSK. Started Mar 2018; status: completed.
02
Drugs
daprodustat
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT03409107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03409107.